Newsroom

For media inquiries, please contact 340B Health Senior VP of Communications Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.

• STATEMENT ON BAUSCH HEALTH RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  July 01, 2022 in 340B Health News Releases

• HRSA DIRECTS UCB TO RESTORE 340B PRICING TO SAFETY-NET HOSPITALS

  June 27, 2022 in 340B Health News Releases

• 340B HOSPITALS REMAIN ON THE FRONT LINES OF THE NATIONAL CAMPAIGN TO PURSUE HEALTH EQUITY

  June 16, 2022 in 340B Health News Releases

• U.S. SUPREME COURT STRIKES DOWN MEDICARE CUTS TO 340B HOSPITALS

  June 15, 2022 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS THREE NEW MEMBERS

  May 25, 2022 in 340B Health News Releases

• FIVE HOSPITAL ASSOCIATIONS URGE APPEALS COURTS TO BACK 340B ENFORCEMENT

  May 17, 2022 in 340B Health News Releases

• FINANCIAL LOSSES FROM DRUG COMPANIES’ 340B RESTRICTIONS HAVE MORE THAN DOUBLED SINCE THE END OF 2021

  May 05, 2022 in 340B Health News Releases

• STATEMENT ON GOVERNMENT APPEAL OF COURT DECISION IN ASTRAZENECA 340B CONTRACT PHARMACY LAWSUIT

  April 13, 2022 in 340B Health News Releases

• STUDY DEMONSTRATES ESSENTIAL ROLE OF 340B AMID COVID-19 CHALLENGES AND DRUG COMPANY RESTRICTIONS

  April 07, 2022 in 340B Health News Releases

• BOEHRINGER INGELHEIM REFERRED FOR PENALTIES FOR CONTINUED VIOLATIONS OF FEDERAL LAW ON 340B PRICING

  March 29, 2022 in 340B Health News Releases

• Hospital groups worry as more drugmakers limit 340B discounts

  March 25, 2022 in 340B in the News

• STATEMENT ON JOHNSON & JOHNSON RESTRICTING 340B DISCOUNTS

  March 21, 2022 in 340B Health News Releases